Cardiorenal Syndrome Type 1: Activation of Dual Apoptotic Pathways

Publisher： Karger

E-ISSN： 1664-5502|5|4|306-315

ISSN： 1664-3828

Source： Cardiorenal Medicine, Vol.5, Iss.4, 2015-0, pp. : 306-315

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Hemodynamic and Nonhemodynamic Crosstalk in Cardiorenal Syndrome Type 1

By  

Cardiorenal Medicine, Vol. 4, Iss. 2, 2014-05 ,pp. : 103-112

Karger

Access to resources Recommend Favorite

Cardiorenal Syndrome Type 4: A Review

By  

Cardiorenal Medicine, Vol. 3, Iss. 1, 2013-03 ,pp. : 63-70

Karger

Access to resources Recommend Favorite

Cardiorenal Syndrome Type 4: Management

By  

Blood Purification, Vol. 36, Iss. 3-4, 2013-12 ,pp. : 200-209

Karger

Access to resources Recommend Favorite

Cardiorenal Syndrome Type 5 in Sepsis: Role of Endotoxin in Cell Death Pathways and Inflammation

By  

Kidney and Blood Pressure Research, Vol. 41, Iss. 6, 2016-12 ,pp. : 1008-1015

Karger

Access to resources Recommend Favorite

Possible Mechanisms of Local Tissue Renin-Angiotensin System Activation in the Cardiorenal Metabolic Syndrome and Type 2 Diabetes Mellitus

By  

Cardiorenal Medicine, Vol. 1, Iss. 3, 2011-07 ,pp. : 193-210

Karger

Access to resources Recommend Favorite